New clinical trial for treatment of COVID-19 positive patients to start at NYU Grossman School of Medicine in partnership with Montreal Heart Institute
Home > Press room > New clinical trial for treatment of COVID-19 positive patients to start at NYU Grossman School of Medicine in partnership with Montreal Heart Institute
Copied link!
Share
April 6, 2020
─
The Montreal Heart Institute Research Center today announced a strategic partnership with the NYU Grossman School of Medicine in New York City for its COVID-19 clinical study to evaluate whether colchicine will have an effect on preventing the phenomenon of major inflammatory storm present in adults suffering from severe complications related to COVID-19.
find out more by visiting the Institute’s website
Physicians with patients, or people with a positive COVID-19 diagnosis who are interested in participating in the clinical study, can call the hotline any time at 1-877-536-6837.
Press Room
December 6, 2023The Right Honourable Brian Mulroney and Mrs. Mila Mulroney donate $1.5 million to support the foundations of two hospitals and a research institute
October 31, 2023Céline Auger, Dominique Morency-Laflamme, and Isabelle Gauthier named recipients of the 2023 Dr. Denis Roy Awards for Excellence in Cardiovascular Care
September 8, 202323rd edition of the Grand Bal des Vins-Cœurs: $1,380,000 raised for the Montreal Heart Institute Foundation